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 For a quarter century, nephrologists treat-
ing hyponatremia have struggled with a 
dilemma. On the one hand, some authors 
have written that symptomatic  hypo-
natremia has an unacceptably high mortal-
ity rate unless it is treated aggressively. On 
the other hand, some have linked overag-
gressive therapy to a crippling or fatal neu-
rological complication known as osmotic 
demyelination syndrome, or central pon-
tine myelinolysis (CPM). In the early days 
of this controversy,  Kidney International 
devoted a Nephrology Forum to this 
conundrum, characterizing it as  ‘ damned 
if we do and damned if we don ’ t ’. 1 
 Th ree years ago, a Commentary in this 
journal revisited the controversy and took 
a strong stand, asserting that  ‘ one must 
conclude that we are damned if we don ’ t, 
or at least the patient is ’. 2 Th e article main-
tained that because of the high mortality 
risk, symptomatic hyponatremic patients 
 ‘ should receive rapid correction of their 
sodium concentration to safe levels. ’ An 
increase of 8 – 10 mequiv. per liter in 
sodium concentration in the fi rst 4 – 6  h 
was advised, followed by correction to 
about 120 mequiv. per liter in the next 
24  h, with correction of the remaining 
defi cit  ‘ at a rate that improves serum con-
centration each 24  h by 50 % of the desired 
fi nal sodium concentration. ’ Emphasizing 
the additive risks of hypoxia in sympto-
matic hyponatremia, the Commentary 
recommended intensive care and endo-
tracheal intubation if the arterial partial 
 pressure of oxygen (PO 2 ) falls below 
70  mm  Hg. While acknowledging CPM as 
a theoretical possibility, the writer con-
cluded,  ‘ our therapeutic approaches 
should not be paralyzed by fear that CPM 
will develop. ’ In support of these conclu-
sions, the Commentary cited experimen-
tal fi ndings suggesting that brain damage 
in hyponatremia is the result of hypoxia 
rather than overzealous therapy. 3 
 In this issue of the journal, Gankam 
Kengne and colleagues 4 present experimen-
tal fi ndings that are diffi  cult to reconcile 
with the notion that the histologic lesions of 
osmotic demyelination syndrome result 
from hypoxia rather than excessive correc-
tion of hyponatremia. In the chronically 
hyponatremic rat, almost uniformly fatal 
brain lesions can be consistently induced by 
an increase of the serum sodium by more 
than 20 mequiv. per liter per day. Re-lower-
ing the serum sodium concentration 
reverses the breakdown of the blood – brain 
barrier caused by rapid correction and pre-
vents brain damage and mortality. Interest-
ingly, the investigators fi nd that opening of 
the blood – brain barrier, one of the proposed 
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 Overcorrection of hyponatremia 
is a medical emergency 
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 Overcorrection of hyponatremia is a medical emergency. Excessive 
correction usually results from the unexpected emergence of a water 
diuresis after resolution of the cause of water retention. The concurrent 
administration of desmopressin and 5 % dextrose in water can be given 
to cautiously re-lower the serum sodium concentration when 
therapeutic limits have been exceeded. Nephrologists should be equally 
aggressive in correcting hyponatremia and in un-correcting it when 
their patients get too much of a good thing. 
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mechanisms for demyelination, may be an 
epiphenomenon, because glucocorticoids 
are equally eff ective in protecting the blood –
 brain barrier but relatively  ineffective in 
preventing brain lesions or mortality. 
 Clinical experience validates these exper-
imental fi ndings. Early manifestations of 
osmotic demyelination following excessive 
correction of hyponatremia have been 
reversed in individual case reports by re-
lowering of the serum sodium concentra-
tion. 5,6 We routinely use desmopressin to 
prevent the serum sodium from increasing 
more than it should, and we have frequently 
administered 5 % dextrose in water with 
desmopressin to re-lower the serum sodium 
aft er inadvertent overcorrection of sympto-
matic hyponatremia; our published and 
confi rmatory unpublished experiences with 
this maneuver have shown that it is well 
tolerated. 5 If symptomatic hyponatremia 
carries a high risk of seizures, respiratory 
arrests, neurogenic pulmonary edema, and 
hypoxic exacerbation of cerebral edema 
leading to fatal herniation, how is it possible 
that patients do well when their serum 
sodium concentration is re-lowered into 
the  ‘ unsafe ’ hyponatremic range? Perhaps 
we should reexamine the evidence. 
 To be sure, even mild hyponatremia is 
associated with increased hospital 
 mortality. 7 We really do not understand 
why this is true, but fatal cases are rarely 
associated with clinical evidence of cerebral 
edema or, for that matter, osmotic demyeli-
nation. Studies suggesting that respiratory 
arrest culminating in brain damage or 
death is a common complication of 
 symptomatic hyponatremia consist of cases 
 ‘ referred ’ to the authors aft er the patients 
had already died or suff ered irreversible 
brain damage. 8 Case series free of selection 
bias suggest that osmotic demyelination 
due to overcorrection of hyponatremia is 
more common than respiratory arrest from 
inadequately treated hyponatremia. 6 
 What is the evidence that hypoxia rather 
than overcorrection of hyponatremia 
causes demyelinating brain lesions? Ayus 
and colleagues demonstrated that severe 
hypoxia exacerbates brain edema in 
hyponatremic animals. 3 If this occurs in 
humans, hypoxia from neurogenic pulmo-
nary edema might plausibly cause a vicious 
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hyponatremia, we believe, should prevent 
the most devastating consequences of 
hyponatremia while minimizing the chance 
of osmotic demyelination in any patient, par-
ticularly those with chronic hyponatremia. 
 Overcorrection of hyponatremia should 
be viewed as a medical emergency. In most 
cases, excessive correction results from the 
unexpected emergence of a water diuresis 
aft er resolution of the cause of water reten-
tion (medications, hypovolemia, transient 
syndrome of inappropriate antidiuretic 
hormone, and so on). 5,14 Th e surest way to 
avoid inadvertent overcorrection in a 
patient undergoing a water diuresis is to 
administer desmopressin (but only to 
patients who can be relied on to curtail 
their water intake, and probably not to 
patients with hyperacute hyponatremia 
developing over a few hours). If the serum 
sodium has already increased by more than 
10 – 12 mequiv. per liter in 24  h or 18 
mequiv. per liter in 48  h, the concurrent 
cautious administration of 5 % dextrose in 
water in individual doses of 6  ml per kilo-
gram body weight, given over an hour or 
two (calculated to reduce the serum sodium 
by 2 mequiv. per liter), monitored by serum 
sodium determinations after each dose 
(and before another is given), can be used 
to return the serum sodium concentration 
cycle ending in death. However, these 
investigators were not able to cause demy-
elinating brain lesions with hypoxia. 3 Expo-
sure to severe hypoxia was uniformly and 
immediately fatal in hyponatremic animals. 
Exposure of normonatremic rats to pro-
longed severe hypoxia caused brain lesions 
in 23 % of animals that were similar in dis-
tribution to those caused by rapid correc-
tion of chronic hyponatremia. Although 
the distribution of lesions was similar, their 
histologic characteristics were not. Unlike 
the lesions of osmotic demyelination, which 
spare neurons, hypoxia-induced lesions 
were associated with neuronal necrosis. 
 Why intubate a hyponatremic patient 
because of a PO 2 of 70  mm Hg (a value 
associated with an oxygen saturation 
above 95 % )? In the study by Ayus  et al . , 
fi ve mechanically ventilated hypona tremic 
rats with hypoxia of this severity had a 
significantly lower  ‘ cerebral perfusion 
index ’ than controls or hypona tremic ani-
mals without hypoxia. 3 Th e fi nding seems 
insuffi  cient to merit a clinical mandate: 
the study was small; it provided no infor-
mation on how (or whether) blood pres-
sure and PCO 2 , keys to cerebral perfusion, 
were maintained at equivalent levels 
across groups; and the investigators used 
a technique whose validity has been chal-
lenged to estimate cerebral blood fl ow. 9 
 Certainly, mechanical ventilation can 
result in alterations in blood pressure and 
PCO 2 , factors that do infl uence cerebral 
blood fl ow (for better or worse). 10 Further-
more, a high rate of cerebral perfusion is not 
necessarily desirable. Increasing the serum 
sodium concentration from 111 to 128 
mequiv. per liter over 3  h (a rate known to 
cause osmotic demyelination in the rat) dra-
matically increases cerebral blood fl ow with-
out aff ecting PO 2 , PCO 2 , or blood pressure; 
the surge in blood flow is a prelude to 
breakdown of the blood – brain barrier. 11 
 Directing our attention to cerebral per-
fusion in mechanically ventilated animals 
obscures the most important clinical ques-
tion: what is the consequence of mild to 
moderate hypoxia in spontaneously breath-
ing hyponatremic patients? Even in patients 
with extremely low serum sodium concen-
trations, a linkage between hypoxia and 
adverse neurological outcomes has not been 
established. A recent study of all patients 
with serum sodium concentrations of 110 
mequiv. per liter or less at our medical 
center identifi ed only a handful with oxygen 
saturations below 90 % ; these subjects, like 
those without hypoxia, recovered unevent-
fully aft er treatment designed to limit cor-
rection to less than 12 mequiv. per liter in 
24  h and 18 mequiv. per liter in 48  h. 12 Our 
recent fi ndings confi rm the favorable out-
comes in severe hyponatremia documented 
in an earlier study from the same center. 13 
When it was fashionable to bring serum 
sodium concentrations of 105 mequiv. per 
liter or less into a  ‘ safe range ’ above 120 
mequiv. per liter (a goal that requires an 
increase of more than 15 mequiv. per liter 
within 24  h), half the patients suff ered tem-
porary or permanent post-therapeutic neu-
rological complications. 13 
 We agree that fear of osmotic demyelina-
tion does not justify therapeutic inaction, but 
fear of complications from hyponatremic 
encephalopathy does not justify therapeutic 
excess. Regardless of how oft en it occurs, the 
fact that some patients with acute 
hyponatremia succumb to cerebral edema 
makes this a medical emergency. Fortunately, 
it now appears that an increase in serum 
sodium concentration by 4 – 6 mequiv. per 
liter is suffi  cient to rescue a patient from 
impending herniation. 6 Adopting a strategy 
of prompt but limited correction of 
 Figure 1  |  Idealized depiction of the recommended approach to unintentional overcorrection 
of severe hyponatremia. After the initial antidiuresis (urine osmolality 600  mOsm / kg) converts 
to a water diuresis (urine osmolality 80  mOsm / kg) as the original cause of the antidiuresis resolves , 
administration of desmopressin (DDAVP) concentrates the urine (urine osmolality 700  mOsm / kg), 
terminating the water diuresis that has increased the serum sodium by 18  mmol / l in less than 24  h. 
A brief infusion of 5 % dextrose in water (D5W) re-lowers the serum sodium to a more acceptable 
level, representing a 10-mmol / l increase in 24  h. Continued administration of desmopressin 
at frequent intervals maintains a concentrated urine (700  mOsm / kg), and the concurrent 
administration of 3 % NaCl results in a controlled, predictable, and slow increase in serum sodium 
concentration until therapeutic goals are reached, maintaining correction rates below 
therapeutic limits (18  mmol / l / 48  h and 20  mmol / l / 72  h). 
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to a level below these limits of overcorrec-
tion. Subsequently, a state of controlled 
antidiuresis is maintained by the adminis-
tration of desmopressin every 6 – 8  h, a slow 
increase of the serum sodium concentra-
tion as desired with water restriction plus 
hypertonic saline or salt tablets, or the peri-
odic delaying of a dose of desmopressin to 
permit a brief water diuresis (Figure 1). 
 Both untreated and overtreated 
hyponatremia can result in disastrous neu-
rological complications. We need not choose 
between these evils. Nephrologists should 
be equally aggressive in correcting 
hyponatremia and in un-correcting it when 
their patients get too much of a good thing. 
 DISCLOSURE 
 RHS has been paid honoraria by Astellas and 
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 In this issue of  Kidney International , Yeates 
and colleagues 1 present a well-done inter-
national comparison of the disparities fac-
ing indigenous populations in access to 
kidney transplantation. Using data from 
four national registries, they demonstrate 
that, in comparison with white populations 
of the same age, indigenous people ’ s access 
to transplantation ranges from very poor 
(US hazard ratio of 0.44) to extremely poor 
(Australia and New Zealand hazard ratio of 
0.23). Despite the diff erences in the health-
care systems, the disparities persisted. 
 Documenting disparities in medical 
care for minority populations is hardly 
news. Hundreds of publications appear in 
the literature each year showing varying 
levels of disparity across the entire range 
of medicine and health outcomes. 
 Transplantation presents an intriguing 
(and exasperating) study in the seem-
ingly intractable problem of ethnic and 
racial barriers to access. First, the rele-
vant target population (people with end-
stage renal disease) is relatively easy to 
defi ne. Second, the preferred outcome 
(transplantation) is easy to measure, and 
the desirability of the outcome is almost 
unequivocal. Transplantation is simply a 
superior alternative to dialysis. Finally, 
the underlying racial discrepancies have 
been well documented for more than 20 
years. 2,3 Reducing racial disparities has 
been a long-time goal of the transplanta-
tion community, with many eff orts to 
increase minority registration on wait 
lists among organ donors. 4 Despite this, 
the relative access of minorities to trans-
plantation remains essentially unchanged 
over the past 20 years. 5 Why is this? 
 The days of easy solutions to racial 
disparities are well behind us. In the 
mid-1960s in the United States there 
were still policies in many states that 
mandated racial segregation of patients 
in hospitals. However, because of the 
creation and enactment of Medicare in 
1966, combined with the rigorous 
enforcement of Title VI of the Civil 
Rights Act, the practice of racial segrega-
tion in hospitals in the United States was 
eliminated in a mere four months. 6 
Thankfully, such blatant and legally 
sanctioned discrimination no longer 
exists. Removing cultural and socioeco-
nomic barriers is altogether diff erent. 
 Obtaining a solid-organ transplant 
involves a number of steps, any one of 
which can present barriers to the event. 
Th ese include referral, assessment, regis-
tration, waiting time, matching criteria, 
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a tough nut to crack 
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 Racial disparities in access to kidney transplantation continue to exist 
despite determined efforts to improve minority access. Subtle barriers 
to transplant access will be difficult to overcome. However, the gap 
between the number of persons needing transplant and the available 
organs is the greatest impediment to transplantation equality. 
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